58 /100
HIGH RISK
Score updated May 30, 2026

GTHP — Guided Therapeutics, Inc. Dilution Risk Tracker

Track GTHP dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track GTHP — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
85
📊 Float Risk
55
⚠️ Warrant Exposure
90
🔄Convertible Debt—

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
60%
🔄 Reverse Split 70%
• 50-day avg $0.21 below $1 exchange minimum
• Only 5 months cash — financial pressure
📜 Warrant Exercise 60%
• Massive warrant overhang: 37% of shares outstanding
• Warrant risk score very high (90/100)
💰 Capital Raise 35%
• Low cash runway: 5 months remaining
🔔 Track GTHP — Get forecast alerts →

💹 Market Data

Market Cap$22.11M
Shares Outstanding96.54M
Float40.10M
Cash$369.0K
Debt$2.79M
Short InterestN/A

🏛 Institutional Holdings

Institutional data not yet available.

📉 Short Interest

Short Interest42.4K
Days to Cover1.0
% of Float0.1%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2025
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track GTHP Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking GTHP — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: BATL BRN CDIO CDT CNTMD
🔬 More Research for GTHP
📊 GTHP FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 GTHP Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.